SFA Therapeutics Shifts Leadership as Drug Programs Advance
JENKINTOWN, PA — SFA Therapeutics has installed Chairman Shawn Patrick O’Brien as chief executive officer as the biotechnology company prepares to advance its lead psoriasis drug into Phase 2 development …
SFA Therapeutics Shifts Leadership as Drug Programs Advance Read More